Lataa...
Targeting innate immunity to downmodulate adaptive immunity and reverse type 1 diabetes
Type 1 diabetes (T1D) is characterized by specific destruction of pancreatic insulin-producing beta cells accompanied by evidence of beta-cell-directed autoimmunity such as autoreactive T cells and islet autoantibodies (IAAs). Currently, T1D cannot be prevented or reversed in humans. T1D is easy to...
Tallennettuna:
| Julkaisussa: | Immunotargets Ther |
|---|---|
| Päätekijät: | , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Dove Medical Press
2017
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5448691/ https://ncbi.nlm.nih.gov/pubmed/28580341 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/ITT.S117264 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|